From: Long-course neoadjuvant chemoradiotherapy with versus without a concomitant boost in locally advanced rectal cancer: a randomized, multicenter, phase II trial (FDRT-002)
Arm A
Arm B
Total
P value
No.
%
pCR
8
13.3%
14
23.3%
22
18.3%
non-pCR
52
86.7%
46
76.7%
98
81.7%
.157
Response
Good
18
30.0%
33
55.0%
51
42.5%
Poor
42
70.0%
27
45.0%
69
57.5%
.006